neuroendocrine carcinomas

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

May, 2025

neuroendocrine carcinomas

Jun 5, 2024, 10:46 | Blog

Mohammad Jad showcased work on small cell neuroendocrine carcinomas at ASCO24 - MD Anderson Cancer Center

Mohammad Jad Moussa, GU Oncologist at MD Anderson Cancer Center, shared a post by MD…

May 28, 2024, 04:25 | Insight

Arndt Vogel: A randomized phase II trial of Captem or Folfiri as second-line therapy in neuroendocrine carcinomas

Arndt Vogel shared on X: “A randomized phase II trial of Captem or Folfiri as…

Mar 31, 2024, 08:44 | Blog

UCLA Health Jonsson Comprehensive Cancer Center's presentation at the annual meeting of the American Association for Cancer Research (AACR)

Investigators from the UCLA Health Jonsson Comprehensive Cancer Center will discuss the latest breakthroughs and cutting-edge science…

Jan 28, 2024, 18:44 | Blog

Interim phase 1 results show HPN328 is well tolerated and clinically active for neuroendocrine carcinomas - Dana-Farber News

Dana-Farber News recently shared a post on their X/Twitter page: "ASCO GU24: Interim phase 1…

All: 4 Posts: 1 - 100

'

In Memory of Bob Marley: His Battle with Melanoma and the Importance of Early Detection

'

Who From Oncology is Featured in TIME100 Health 2025?

'

FDA Announces Aggressive Timeline to Scale 1st AI-Assisted Scientific Review Pilot

'

The Evolving Therapeutic Revolution in Adult Acute Lymphoblastic Leukemia

'

Francesco Acerbi and Testicular Cancer: The Defender's Fight and Triumphant Return to Football

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023